Once-weekly Lilly diabetes GLP-1 agonist wins EU approval
http://uk.reuters.com/article/2014/11/25/us-diabetes-lilly-idUKKCN0J925220141125?feedType=RSS&feedName=healthNews
"Regulators in Europe have given the green light to Eli Lilly’s Trulicity, its once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes."
http://www.pharmatimes.com/mobile/14-11-25/eu_approves_lilly_diabetes_drug_trulicity.aspx?r=1
https://en.wikipedia.org/wiki/Dulaglutide
http://uk.reuters.com/article/2014/11/25/us-diabetes-lilly-idUKKCN0J925220141125?feedType=RSS&feedName=healthNews
"Regulators in Europe have given the green light to Eli Lilly’s Trulicity, its once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes."
http://www.pharmatimes.com/mobile/14-11-25/eu_approves_lilly_diabetes_drug_trulicity.aspx?r=1
https://en.wikipedia.org/wiki/Dulaglutide
No comments:
Post a Comment